Accendra Health, Inc. (ACH)
NYSE: ACH · Real-Time Price · USD
2.200
+0.060 (2.80%)
Jan 22, 2026, 1:16 PM EST - Market open
Accendra Health Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Accendra Health stock has a target of 4.00, which predicts a 81.82% increase from the current stock price of 2.2.
Price Target: $4.00 (+81.82%)
Analyst Consensus: Strong Buy
Analyst Ratings
According to 1 stock analyst, the rating for Accendra Health is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 |
|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 1 |
| Buy | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Maintains $7 → $4 | Strong Buy | Maintains | $7 → $4 | +81.82% | Jan 9, 2026 |
| Goldman Sachs | Goldman Sachs | Strong Sell → Hold Upgrades n/a | Strong Sell → Hold | Upgrades | n/a | n/a | Aug 25, 2022 |
| Macquarie | Macquarie | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Jan 3, 2020 |
Financial Forecast
Revenue This Year
2.80B
from 10.70B
Decreased by -73.86%
Revenue Next Year
2.63B
from 2.80B
Decreased by -5.97%
EPS This Year
1.04
from -4.73
EPS Next Year
0.95
from 1.04
Decreased by -8.82%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 2.9B | 2.8B | ||
| Avg | 2.8B | 2.6B | ||
| Low | 2.7B | 2.5B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | -72.8% | 1.5% | ||
| Avg | -73.9% | -6.0% | ||
| Low | -74.7% | -11.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.11 | 1.05 | |||
| Avg | 1.04 | 0.95 | |||
| Low | 0.99 | 0.80 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | 1.1% | |||
| Avg | - | -8.8% | |||
| Low | - | -22.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.